Long-term sequelae of COVID-19 (myalgic encephalomyelitis): An international cross-sectional study.

Published in: Medicine (2022)

A large cohort of people from all over the world will be examined to understand the differential effects of people who have experienced COVID-19, as well as the potential occurrence of ME. In total, 20,000 COVID patients are expected to be included in the study by Sep 1, 2022. Patients who have experienced COVID-19 will be asked about their persistent symptoms from 1 week up to more than 6 months after catching or recovery from the infection.

Keyphrases

sars cov
coronavirus disease
end stage renal disease
respiratory syndrome coronavirus
ejection fraction
newly diagnosed
risk assessment
clinical trial
patient reported outcomes
climate change
depressive symptoms
sleep quality